Search for Clinical Trial Results
Glucagonoma - 50 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Capecitabine, Temozolomide and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors Condition:
|
Active, not recruiting |
Study Name: Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Condition:
|
Completed |
Study Name: Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Condition:
|
Terminated |
Study Name: Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors Condition:
|
Completed |
Study Name: Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors Condition:
|
Terminated |
Study Name: Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer Condition:
|
Completed |
Study Name: Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu Condition:
|
Completed |
Study Name: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Condition:
|
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer Condition:
|
Recruiting |
Study Name: Laser Tissue Welding - Distal Pancreatectomy Sealing Study Condition:
|